Trial Outcomes & Findings for Feasibility Study of the Magnetic Anal Sphincter (FENIX System) (NCT NCT01625221)
NCT ID: NCT01625221
Last Updated: 2018-01-03
Results Overview
The safety objective will be met via reporting all adverse events at various time points including implant, 6 weeks, 3 months, 6 months, and 12 months (and then semi-annually until 5 years post-implant at U.S. sites). Serious device- and procedure-related adverse events will be summarized separately. Safety will be characterized by physical examination and pelvic X-ray evaluations.
COMPLETED
NA
35 participants
60 months
2018-01-03
Participant Flow
Participant milestones
| Measure |
Magnetic Anal Sphincter Augmentation
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Overall Study
STARTED
|
35
|
|
Overall Study
COMPLETED
|
28
|
|
Overall Study
NOT COMPLETED
|
7
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Feasibility Study of the Magnetic Anal Sphincter (FENIX System)
Baseline characteristics by cohort
| Measure |
Magnetic Anal Sphincter Augmentation
n=35 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Age, Continuous
|
64.1 years
STANDARD_DEVIATION 9.7 • n=5 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
18 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
17 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
34 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=5 Participants
|
|
Region of Enrollment
France
|
15 participants
n=5 Participants
|
|
Region of Enrollment
United States
|
15 participants
n=5 Participants
|
|
Region of Enrollment
Denmark
|
5 participants
n=5 Participants
|
|
Fecal incontinence episodes
|
13.9 episodes per week
STANDARD_DEVIATION 6.7 • n=5 Participants
|
PRIMARY outcome
Timeframe: 60 monthsPopulation: All adverse events as reported by investigators
The safety objective will be met via reporting all adverse events at various time points including implant, 6 weeks, 3 months, 6 months, and 12 months (and then semi-annually until 5 years post-implant at U.S. sites). Serious device- and procedure-related adverse events will be summarized separately. Safety will be characterized by physical examination and pelvic X-ray evaluations.
Outcome measures
| Measure |
Magnetic Anal Sphincter Augmentation
n=35 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Adverse Events
All Adverse Events
|
223 Number of events
|
|
Adverse Events
Serious Device or Procedure-related Adverse Events
|
7 Number of events
|
PRIMARY outcome
Timeframe: 12 MonthsEffectiveness will be characterized as the reduction of FI symptoms by subjective measurements using the FISI, Wexner, and FIQOL scores and a three week diary documenting episodes of incontinence.
Outcome measures
| Measure |
Magnetic Anal Sphincter Augmentation
n=28 Participants
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Reduction in Fecal Incontinence Symptoms
|
3.8 episodes per week
Standard Deviation 5.1
|
Adverse Events
Magnetic Anal Sphincter Augmentation
Serious adverse events
| Measure |
Magnetic Anal Sphincter Augmentation
n=35 participants at risk
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Infections and infestations
Infection
|
11.4%
4/35
|
|
Skin and subcutaneous tissue disorders
Device erosion
|
2.9%
1/35
|
|
Gastrointestinal disorders
Impaction or defecatory disorder
|
2.9%
1/35
|
|
Immune system disorders
Allergy, inflammation reaction
|
2.9%
1/35
|
Other adverse events
| Measure |
Magnetic Anal Sphincter Augmentation
n=35 participants at risk
The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
Magnetic Anal Sphincter: The implantable single-use Magnetic Anal Sphincter (FENIX) device consists of a series of titanium beads with magnetic cores that are linked together with independent titanium wires forming an annular shape. The device is supplied sterile and is placed through an open incision.
|
|---|---|
|
Skin and subcutaneous tissue disorders
Device erosion
|
8.6%
3/35
|
|
Gastrointestinal disorders
Pain
|
17.1%
6/35
|
|
Gastrointestinal disorders
Impaction or defecatory disorder
|
5.7%
2/35
|
|
Gastrointestinal disorders
Rectal bleeding
|
2.9%
1/35
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60